2022 - Research.com Best Female Scientist Award
2022 - Research.com Best Scientist Award
Jane A. Cauley mostly deals with Internal medicine, Osteoporosis, Bone density, Surgery and Risk factor. Her study looks at the intersection of Internal medicine and topics like Endocrinology with Physiology. Her biological study spans a wide range of topics, including Physical therapy and Calcaneus.
Within one scientific family, Jane A. Cauley focuses on topics pertaining to Body mass index under Bone density, and may sometimes address concerns connected to Cohort. Her studies deal with areas such as Placebo, Bone remodeling, Osteopenia and Urology as well as Surgery. Her Risk factor research incorporates elements of Physical fitness, Weight change and Confidence interval.
Jane A. Cauley spends much of her time researching Internal medicine, Osteoporosis, Prospective cohort study, Bone density and Endocrinology. Hazard ratio, Body mass index, Hip fracture, Breast cancer and Confidence interval are subfields of Internal medicine in which her conducts study. Her Osteoporosis research focuses on subjects like Surgery, which are linked to Placebo.
Her work investigates the relationship between Prospective cohort study and topics such as Gerontology that intersect with problems in Demography and Epidemiology. Her Bone density study frequently draws connections to adjacent fields such as Femur. In the field of Endocrinology, her study on Estrogen, Menopause, Vitamin D and neurology and Sex hormone-binding globulin overlaps with subjects such as Context.
Jane A. Cauley mainly focuses on Internal medicine, Osteoporosis, Demography, Bone mineral and Prospective cohort study. As part of the same scientific family, Jane A. Cauley usually focuses on Internal medicine, concentrating on Endocrinology and intersecting with Placebo. Her work carried out in the field of Osteoporosis brings together such families of science as Physical therapy, Epidemiology and Incidence.
Her Demography study incorporates themes from Relative risk, Logistic regression and Obesity. Her research investigates the connection between Bone mineral and topics such as Femoral neck that intersect with issues in Risk factor. Jane A. Cauley has researched Prospective cohort study in several fields, including Proportional hazards model and Cohort.
The scientist’s investigation covers issues in Internal medicine, Osteoporosis, Prospective cohort study, Confidence interval and Hip fracture. Her Internal medicine research incorporates themes from Placebo and Surgery. Much of her study explores Osteoporosis relationship to Epidemiology.
She has included themes like Odds ratio and Demography in her Confidence interval study. Her studies in Hip fracture integrate themes in fields like Older population, Incidence, Bone remodeling and Obstetrics. Her Bone mineral study integrates concerns from other disciplines, such as Menopause and Dentistry.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group.
Steven R. Cummings;Michael C. Nevitt;Warren S. Browner;Katie Stone.
The New England Journal of Medicine (1995)
Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures
Dennis M Black;Steven R Cummings;David B Karpf;Jane A Cauley.
The Lancet (1996)
Gait speed and survival in older adults.
Stephanie Studenski;Subashan Perera;Kushang Patel;Caterina Rosano.
JAMA (2011)
Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis
Dennis M. Black;Pierre D. Delmas;Richard Eastell;Ian R. Reid.
The New England Journal of Medicine (2007)
Bone density at various sites for prediction of hip fractures
S R Cummings;D M Black;M C Nevitt;W Browner.
The Lancet (1993)
The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women: Results From the MORE Randomized Trial
Steven R. Cummings;Stephen Eckert;Kathryn A. Krueger;Deborah Grady.
JAMA (1999)
Cardiovascular Disease Outcomes During 6.8 Years of Hormone Therapy: Heart and Estrogen/Progestin Replacement Study Follow-up (HERS II)
Stephen Hulley;Curt Furberg;Elizabeth Barrett-Connor;Jane Cauley.
JAMA (2002)
Calcium plus vitamin D supplementation and the risk of fractures.
Rebecca D. Jackson;Andrea Z. LaCroix;Margery Gass;Robert B. Wallace.
The New England Journal of Medicine (2006)
Bisphosphonate-associated osteonecrosis of the jaw: Report of a Task Force of the American Society for Bone and Mineral Research
Sundeep Khosla;David Burr;Jane Cauley;David W. Dempster.
Journal of Bone and Mineral Research (2007)
Common genetic determinants of vitamin D insufficiency: a genome-wide association study
Thomas J. Wang;Feng Zhang;J. Brent Richards;Bryan Kestenbaum.
The Lancet (2010)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Minnesota
University of California, San Francisco
University of California, San Francisco
Oregon Health & Science University
California Pacific Medical Center
University of Pittsburgh
University of California, San Francisco
National Institutes of Health
University of California, San Diego
University of California, San Francisco
Polytechnic University of Milan
New York University Shanghai
Karlsruhe Institute of Technology
Central China Normal University
Novartis (United States)
Plymouth University
Kyoto University
University of Cambridge
INRAE : Institut national de recherche pour l'agriculture, l'alimentation et l'environnement
University of Edinburgh
University of Tasmania
University of Santiago de Compostela
Birkbeck, University of London
Brigham and Women's Hospital
McMaster University
Education Development Center